[Federal Register Volume 64, Number 78 (Friday, April 23, 1999)]
[Notices]
[Pages 19977-19978]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-10130]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board
[Order No. 1036]


Grant of Authority for Subzone Status; PFIZER 
Inc.(Pharmaceuticals); Brooklyn, New York

    Pursuant to its authority under the Foreign-Trade Zones Act of June 
18, 1934, as amended (19 U.S.C. 81a-81u), the Foreign-Trade Zones Board 
(the Board) adopts the following Order:
    Whereas, the Foreign-Trade Zones Act provides for ``* * * the 
establishment* * * of foreign-trade zones in ports of entry of the 
United States, to expedite and encourage foreign commerce, and for 
other purposes,'' and authorizes the Foreign-Trade Zones Board to grant 
to qualified corporations the privilege of establishing foreign-trade 
zones in or adjacent to U.S. Customs ports of entry;
    Whereas, the Board's regulations (15 CFR part 400) provide for the 
establishment of special-purpose subzones when existing zone facilities 
cannot serve the specific use involved;
    Whereas, the City of New York, grantee of Foreign-Trade Zone 1, has 
made application to the Board for authority to establish special-
purpose subzone status at the pharmaceutical manufacturing plant of 
Pfizer Inc., located in Brooklyn, New York (FTZ Docket 49-98, filed 11/
3/98, amended 1/12/99);

[[Page 19978]]

    Whereas, notice inviting public comment was given in the Federal 
Register (63 FR 63451, 11/13/98); and,
    Whereas, the Board adopts the findings and recommendations of the 
examiner's report, and finds that the requirements of the FTZ Act and 
Board's regulations are satisfied, and that approval of the 
application, as amended, is in the public interest;
    Now, Therefore, the Board hereby grants authority for subzone 
status at the pharmaceutical manufacturing plant of Pfizer Inc., 
located in Brooklyn, New York (Subzone 1A), at the location described 
in the application, and subject to the FTZ Act and the Board's 
regulations, including Sec. 400.28.

    Signed at Washington, DC, this 7th day of April 1999.
Robert S. LaRussa,
Assistant Secretary of Commerce for Import Administration, Alternate 
Chairman, Foreign-Trade Zones Board.
[FR Doc. 99-10130 Filed 4-22-99; 8:45 am]
BILLING CODE 3510-DS-P